Market Cap (In KRW)
271.86 Billion
Revenue (In KRW)
278.94 Billion
Net Income (In KRW)
48.26 Billion
Avg. Volume
30.24 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 17250.0-28900.0
- PE
- -
- EPS
- -
- Beta Value
- 0.331
- ISIN
- KR7033270000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Duk-Young Kang
- Employee Count
- -
- Website
- https://www.kup.co.kr
- Ipo Date
- 2000-02-11
- Details
- Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.
More Stocks
-
GFAIW
-
BRE2
-
AGSVFArgentum Silver Corp.
AGSVF
-
6643
-
JYOTISTRUCJyoti Structures Limited
JYOTISTRUC
-
FTE
-
PATINTLOGPatel Integrated Logistics Limited
PATINTLOG
-
9524